Chemotherapy-induced Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-09-28Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial of Hetrombopag Olamine Tablets for chemotherapy-induced thrombocytopenia in solid tumour patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-01-19Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. [Phase 3]
Phase 3 trial of romiplostim for chemotherapy-induced thrombocytopenia in adults with lymphoma was withdrawn.